Skip to main content
Sinocare Inc. logo

Sinocare Inc. — Investor Relations & Filings

Ticker · 300298 ISIN · CNE100001CJ0 LEI · 3003008DEKI00A51LU77 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,252 across all filing types
Latest filing 2013-12-09 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 300298

About Sinocare Inc.

https://www.sinocare.com

Sinocare Inc. specializes in the research, development, and manufacturing of biosensor technology and rapid testing products for chronic disease management. The company is primarily recognized for its blood glucose monitoring systems, including meters and test strips, which serve a global patient base. Its product portfolio extends to point-of-care testing (POCT) solutions for HbA1c, uric acid, blood lipids, and other metabolic indicators. Through the integration of advanced sensing technologies and digital health platforms, Sinocare provides comprehensive diagnostic tools for diabetes and related metabolic disorders. The company focuses on delivering affordable and accurate monitoring solutions to improve the quality of life for individuals with chronic conditions worldwide.

Recent filings

Filing Released Lang Actions
北京国枫凯文律师事务所关于公司股票期权与限制性股票激励计划授予事项的法律意见书
Audit Report / Information Classification · 95% confidence The document is a legal opinion letter issued by Beijing Grandway Law Offices regarding the stock option and restricted stock incentive plan grant matters of SanNuo Biological Sensor Co., Ltd. It details the legal review and verification of the approval, authorization, grant date, grant objects, quantities, and conditions of the stock incentive plan. The document is a standalone legal opinion on a specific corporate action related to stock incentives, not a full annual or interim financial report, nor an announcement or presentation. It does not contain financial statements or earnings data but focuses on legal compliance and authorization of stock incentive grants. This fits the category of Audit Report / Information (AR), which includes applied accounting principles and regulatory or internal compliance reports related to corporate actions, excluding full annual reports or earnings releases. FY 2013
2013-12-09 Chinese
2013年第三次临时股东大会的法律意见
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the convening, procedures, and voting results of a specific shareholders' meeting (the 2013 third extraordinary general meeting) of the company. It details the legality and validity of the meeting's call, attendance, and voting on stock option and restricted stock incentive plans. The document does not contain financial statements or financial performance data, nor is it a transcript or presentation. It is a legal opinion related to a shareholders' meeting and the voting results of specific proposals. This fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it reports official voting results and legal validation of the meeting and resolutions.
2013-12-06 Chinese
2013年第三次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a detailed announcement of the resolutions passed at the 2013 third extraordinary general meeting of shareholders of 三诺生物传感股份有限公司. It includes voting results on various proposals related to stock option and restricted stock incentive plans, details on meeting attendance, voting procedures, and legal opinions confirming the validity of the meeting and resolutions. There is no financial data or report content, but rather the official results of shareholder votes at a general meeting. This matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is about 4837 characters, which is sufficient for a full voting results announcement, not just a brief notice or report publication announcement.
2013-12-06 Chinese
关于召开2013年第三次临时股东大会的提示性公告
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed announcement regarding the convening of the 2013 third extraordinary general meeting (临时股东大会) of 三诺生物传感股份有限公司. It includes information about the meeting time, location, voting procedures (including online voting), agenda items (mainly about stock option and restricted stock incentive plans), registration methods, contact details, and proxy forms. The document does not contain financial statements or results but is focused on informing shareholders about the meeting logistics and agenda. It is not a report of voting results, nor a management or earnings report. It is a notice about the meeting itself, which fits the category of a Proxy Solicitation & Information Statement (PSI), as it provides materials sent to shareholders to inform and request votes for the meeting.
2013-12-02 Chinese
中信证券股份有限公司关于公司股票期权与限制性股票激励计划（草案修订稿）之独立财务顾问报告
Audit Report / Information Classification · 95% confidence The document is an Independent Financial Advisor Report by CITIC Securities regarding a stock option and restricted stock incentive plan for SanNuo Biological Sensor Co., Ltd. It includes detailed definitions, assumptions, plan content, allocation, pricing, performance conditions, legal opinions, and financial accounting treatment related to the stock incentive plan. The document is lengthy (over 13,000 characters) and contains substantive financial and legal analysis specifically about the stock incentive plan. It is not a general annual or quarterly report, nor is it a simple announcement or certification. It is a standalone advisory report focused on the stock option and restricted stock incentive plan, which fits the category of Audit Report / Information (AR) as it involves independent financial advisory and compliance opinions on a specific financial plan. Therefore, the appropriate classification is AR with high confidence. FY 2013
2013-11-18 Chinese
股票期权与限制性股票激励计划人员名单与分配数量（调整后）
Remuneration Information Classification · 95% confidence The document is a detailed list of personnel involved in a stock option and restricted stock incentive plan, including names, positions, and allocation quantities. It includes specific data on stock options and restricted stock allocations, which is typical of remuneration or compensation disclosures. There is no indication that this is a full annual report, audit report, or financial statement. The document is not a brief announcement or a presentation but a detailed disclosure of stock-based compensation allocations. This fits the category of Remuneration Information, which covers reports detailing compensation for top executives and directors, including stock incentive plans.
2013-11-18 Chinese

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.